Cargando…

Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival

PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Robles Barba, Javier J., Llobera, Aida Sabaté, Cenzano, Cristina Gámez, Martin Marcuartu, Juan J., Martínez, Natalia Romero, Paules Villar, Maria J., Larrañaga, Carla Bettonica, Inglada, Anna Boladeras, Campos, Mariona Calvo, Pous, Albert Font, Guzmán, Maica Galán, Romera, Montserrat Cortés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348503/
https://www.ncbi.nlm.nih.gov/pubmed/37456192
http://dx.doi.org/10.4103/ijnm.ijnm_12_22
_version_ 1785073678729347072
author Robles Barba, Javier J.
Llobera, Aida Sabaté
Cenzano, Cristina Gámez
Martin Marcuartu, Juan J.
Martínez, Natalia Romero
Paules Villar, Maria J.
Larrañaga, Carla Bettonica
Inglada, Anna Boladeras
Campos, Mariona Calvo
Pous, Albert Font
Guzmán, Maica Galán
Romera, Montserrat Cortés
author_facet Robles Barba, Javier J.
Llobera, Aida Sabaté
Cenzano, Cristina Gámez
Martin Marcuartu, Juan J.
Martínez, Natalia Romero
Paules Villar, Maria J.
Larrañaga, Carla Bettonica
Inglada, Anna Boladeras
Campos, Mariona Calvo
Pous, Albert Font
Guzmán, Maica Galán
Romera, Montserrat Cortés
author_sort Robles Barba, Javier J.
collection PubMed
description PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy and to study FDG-PET parameters for the prediction of pathological response and outcome. METHODS: Twenty-five patients with locally advanced esophageal cancer underwent two FDG-PET/CT scans for initial staging and after neoadjuvant chemoradiotherapy. FDG uptake in the primary tumor was calculated in both scans (SUVmax, SULpeak, and TLG). Metabolic response was assessed according to the reduction of PET parameters: complete response (mCR = 100%), partial response (mPR ≥50%), and no response (mNR ≤50%). Pathological response was also classified as complete (pCR), partial (pPR), or no response (pNR). Patients were followed up (range, 8–99 months) determining free-disease interval (FDI) and overall survival (OS). RESULTS: Two patients were excluded due to exitus for nonesophageal-related causes. The metabolic response was observed in 18/23 remaining patients (3mCR, 15 mPR), of which 12/18 patients showed a pathological response (3 pCR, 9 pPR). A major discrepancy was observed in 2 mNR patients who achieved pPR. FDI and OS were longer in patients with metabolic response than nonresponders, but no statistical difference was found. No significant correlation was found between PET parameters and pathological response, FDI, and OS. CONCLUSIONS: FDG-PET/CT is a useful technique to assess response to neoadjuvant chemoradiotherapy in esophageal cancer. Although in this preliminary study, no correlation between metabolic and pathologic response was found and no statistical differences between responders and nonresponders were observed, a tendency of longer FDI and OS was apparently found in responders patients.
format Online
Article
Text
id pubmed-10348503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-103485032023-07-15 Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival Robles Barba, Javier J. Llobera, Aida Sabaté Cenzano, Cristina Gámez Martin Marcuartu, Juan J. Martínez, Natalia Romero Paules Villar, Maria J. Larrañaga, Carla Bettonica Inglada, Anna Boladeras Campos, Mariona Calvo Pous, Albert Font Guzmán, Maica Galán Romera, Montserrat Cortés Indian J Nucl Med Original Article PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy and to study FDG-PET parameters for the prediction of pathological response and outcome. METHODS: Twenty-five patients with locally advanced esophageal cancer underwent two FDG-PET/CT scans for initial staging and after neoadjuvant chemoradiotherapy. FDG uptake in the primary tumor was calculated in both scans (SUVmax, SULpeak, and TLG). Metabolic response was assessed according to the reduction of PET parameters: complete response (mCR = 100%), partial response (mPR ≥50%), and no response (mNR ≤50%). Pathological response was also classified as complete (pCR), partial (pPR), or no response (pNR). Patients were followed up (range, 8–99 months) determining free-disease interval (FDI) and overall survival (OS). RESULTS: Two patients were excluded due to exitus for nonesophageal-related causes. The metabolic response was observed in 18/23 remaining patients (3mCR, 15 mPR), of which 12/18 patients showed a pathological response (3 pCR, 9 pPR). A major discrepancy was observed in 2 mNR patients who achieved pPR. FDI and OS were longer in patients with metabolic response than nonresponders, but no statistical difference was found. No significant correlation was found between PET parameters and pathological response, FDI, and OS. CONCLUSIONS: FDG-PET/CT is a useful technique to assess response to neoadjuvant chemoradiotherapy in esophageal cancer. Although in this preliminary study, no correlation between metabolic and pathologic response was found and no statistical differences between responders and nonresponders were observed, a tendency of longer FDI and OS was apparently found in responders patients. Wolters Kluwer - Medknow 2023 2023-06-08 /pmc/articles/PMC10348503/ /pubmed/37456192 http://dx.doi.org/10.4103/ijnm.ijnm_12_22 Text en Copyright: © 2023 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Robles Barba, Javier J.
Llobera, Aida Sabaté
Cenzano, Cristina Gámez
Martin Marcuartu, Juan J.
Martínez, Natalia Romero
Paules Villar, Maria J.
Larrañaga, Carla Bettonica
Inglada, Anna Boladeras
Campos, Mariona Calvo
Pous, Albert Font
Guzmán, Maica Galán
Romera, Montserrat Cortés
Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title_full Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title_fullStr Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title_full_unstemmed Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title_short Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
title_sort role of (f-18) fluorodeoxyglucose positron emission tomography/computed tomography in the prediction of response to neoadjuvant therapy in esophageal cancer: correlation with pathological response and survival
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348503/
https://www.ncbi.nlm.nih.gov/pubmed/37456192
http://dx.doi.org/10.4103/ijnm.ijnm_12_22
work_keys_str_mv AT roblesbarbajavierj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT lloberaaidasabate roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT cenzanocristinagamez roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT martinmarcuartujuanj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT martineznataliaromero roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT paulesvillarmariaj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT larranagacarlabettonica roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT ingladaannaboladeras roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT camposmarionacalvo roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT pousalbertfont roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT guzmanmaicagalan roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival
AT romeramontserratcortes roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival